Gupta Vishal, Yesilbursa Dilek, Huang Wen Ying, Aggarwal Kul, Gupta Vijaya, Gomez Camilo, Patel Vinod, Miller Andrew P, Nanda Navin C
Department of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Echocardiography. 2008 Feb;25(2):217-27. doi: 10.1111/j.1540-8175.2007.00583.x.
Patent foramen ovale (PFO) is a well-recognized risk factor for ischemic strokes. The true prevalence of PFO among stroke patients is still under debate. Transesophageal echocardiography (TEE) is the "gold standard" in diagnosing PFO but the physiology requires right-to-left atrial shunting. In this report, we evaluate the prevalence of PFO in a diverse group of ischemic stroke patients studied by TEE.
TEE of 1,663 ischemic stroke patients were reviewed for cardiac source of embolism, including PFO and atrial septal aneurysm (ASA). Agitated saline bubble injection was performed to look for right to left atrial shunting. Success of maneuvers to elevate right atrial pressure (RAP) was noted by looking at the atrial septal bulge.
Among 1,435 ischemic stroke patients analyzed, the presence or absence of PFO could not be determined in 32.1% because bulging of the septum could not be demonstrated in patients with negative contrast study despite aggressive maneuvers to elevate RAP. Of the remaining 974 patients, 294 patients (30.2%) had a PFO. The mean age was 61.5 years in both groups, with a bimodal distribution of PFO and the highest prevalence occurring in < or =30-year-old group. Prevalence of PFO was similar in men (32.4%) and women (28.15%, P = 0.15); and in Caucasian (32.1%) and African American (27.7%; P = 0.15). ASA was present in 2.02% and hypermobile septum in 2.49% of the 1,435 patients. PFO was seen in 79.3% of the patients with ASA.
Successful elevation of RAP cannot be achieved in a significant number of patients undergoing TEE and determination of PFO may be difficult. In our series, the true prevalence of PFO among ischemic stroke patients was 30.2% taking into account only those patients who showed no shunting despite bulging of the atrium septum into the left atrium (PFO absent group) during the contrast study. There was no gender or racial difference in the prevalence of PFO, but there was a bimodal distribution in prevalence with age.
卵圆孔未闭(PFO)是缺血性卒中公认的危险因素。PFO在卒中患者中的真实患病率仍存在争议。经食管超声心动图(TEE)是诊断PFO的“金标准”,但其生理机制需要从右向左的心房分流。在本报告中,我们评估了通过TEE研究的不同缺血性卒中患者群体中PFO的患病率。
回顾了1663例缺血性卒中患者的TEE检查结果,以确定心脏栓塞源,包括PFO和房间隔瘤(ASA)。进行了 agitated saline bubble注射以寻找从右向左的心房分流。通过观察房间隔膨出情况来记录提高右心房压力(RAP)操作的成功率。
在分析的1435例缺血性卒中患者中,32.1%的患者无法确定是否存在PFO,因为尽管采取了积极措施提高RAP,但阴性对比研究的患者中仍无法显示房间隔膨出。在其余974例患者中,294例(30.2%)有PFO。两组的平均年龄均为61.5岁,PFO呈双峰分布,在≤30岁组患病率最高。男性PFO患病率(32.4%)与女性(28.15%,P = 0.15)相似;白种人(32.1%)与非裔美国人(27.7%;P = 0.15)相似。在1435例患者中,ASA的发生率为2.02%,房间隔活动度增加的发生率为2.49%。在有ASA的患者中,79.3%可见PFO。
大量接受TEE检查的患者无法成功提高RAP,PFO的判定可能存在困难。在我们的系列研究中,仅考虑那些在对比研究期间尽管房间隔膨入左心房但未显示分流的患者(PFO阴性组),缺血性卒中患者中PFO的真实患病率为30.2%。PFO患病率无性别或种族差异,但患病率随年龄呈双峰分布。